image: Clinical improvement in psoriasis in a patient treated with a single intravenous infusion of AIN457 (3 mg/kg). This image relates to an article that appeared in the Oct. 6 2010, issue of Science Translational Medicine, published by AAAS. The study, by Dr. Wolfgang Hueber of Novartis Institutes for BioMedical Research in Basel, Switzerland, and colleagues was titled, "Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis." view more
Credit: Image courtesy of <i>Science</i>/AAAS